The risk or severity of adverse effects can be increased when Darodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Cimetidine. The risk or severity of adverse effects can be increased when Ivacaftor is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Benidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Enalkiren. The serum concentration of Atorvastatin can be increased when it is combined with Chymostatin. The serum concentration of Atorvastatin can be increased when it is combined with Trandolapril. The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lacidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatril. The serum concentration of Atorvastatin can be increased when it is combined with Zofenopril. The risk or severity of adverse effects can be increased when Perhexiline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pravastatin is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Acenocoumarol. The serum concentration of Atorvastatin can be increased when it is combined with Faldaprevir. The serum concentration of Amodiaquine can be increased when it is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Chlorpropamide. The serum concentration of Atorvastatin can be increased when it is combined with Fosinopril. The risk or severity of adverse effects can be increased when Niludipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Geldanamycin. The risk or severity of adverse effects can be increased when Mibefradil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nevirapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caffeine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ceritinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prednisolone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Omapatrilat. The serum concentration of Atorvastatin can be increased when it is combined with Rivaroxaban. The serum concentration of Atorvastatin can be decreased when it is combined with Cholestyramine. The serum concentration of Atorvastatin can be increased when it is combined with Gabexate. The risk or severity of adverse effects can be increased when Metergoline is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Epigallocatechin Gallate. The risk or severity of adverse effects can be increased when Pinaverium is combined with Atorvastatin. The serum concentration of Lanthanum carbonate can be decreased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. The risk or severity of adverse effects can be increased when Norfloxacin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sulfanilamide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Amprenavir. The risk or severity of adverse effects can be increased when Raloxifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mirtazapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinorelbine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tioconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clemastine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Omeprazole is combined with Atorvastatin. Gemfibrozil may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Pilocarpine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Calcium Carbonate. The risk or severity of adverse effects can be increased when Pimozide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziconotide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lercanidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lisuride is combined with Atorvastatin. Atorvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin. The risk or severity of adverse effects can be increased when Salbutamol is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Nafamostat. The risk or severity of adverse effects can be increased when Cinnarizine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 1,10-Phenanthroline. The risk or severity of adverse effects can be increased when Netupitant is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sertraline is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatrilat. The serum concentration of Atorvastatin can be increased when it is combined with Ranolazine. The risk or severity of adverse effects can be increased when Nefazodone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Quinupristin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dasatinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ribociclib. The risk or severity of adverse effects can be increased when Zafirlukast is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Trimethoprim. The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole. The metabolism of Atorvastatin can be increased when combined with Pentobarbital. The risk or severity of adverse effects can be increased when Metyrapone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methazolamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Repaglinide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Buprenorphine is combined with Atorvastatin. The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glimepiride. The risk or severity of adverse effects can be increased when Prednisone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Doxorubicin is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Colesevelam. The serum concentration of Atorvastatin can be increased when it is combined with S-3304. The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid. The serum concentration of Digoxin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Butoconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with GM6001. The risk or severity of adverse effects can be increased when Ifosfamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Losartan is combined with Atorvastatin. Acipimox may increase the myopathic rhabdomyolysis activities of Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ubenimex. The serum concentration of Atorvastatin can be decreased when it is combined with Enzalutamide. Atorvastatin may increase the anticoagulant activities of Fluindione. The risk or severity of adverse effects can be increased when Clofazimine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat. The serum concentration of Atorvastatin can be decreased when it is combined with Deferasirox. The metabolism of Atorvastatin can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Troglitazone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Perindopril. The serum concentration of Atorvastatin can be increased when it is combined with Vildagliptin. The risk or severity of adverse effects can be increased when Cisapride is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Abafungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Daunorubicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Testosterone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicardipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Kitasamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isradipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Felodipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Vemurafenib. The risk or severity of adverse effects can be increased when Clevidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Docetaxel is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Secobarbital. The risk or severity of adverse effects can be increased when Xylometazoline is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Phenindione. The risk or severity of adverse effects can be increased when Troleandomycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Naftopidil is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Boceprevir. The risk or severity of adverse effects can be increased when Capsaicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Valproic Acid is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Miconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Niacin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cocaine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminum hydroxide. The risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin. The risk or severity of adverse effects can be increased when Etoposide is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Tolazamide. The risk or severity of adverse effects can be increased when Imatinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Spirapril. The risk or severity of adverse effects can be increased when Solithromycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sarilumab is combined with Atorvastatin.